Genomic Health (GHDX) Misses Q2 EPS by 2c

Genomic Health (NASDAQ: GHDX) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $85.5 million versus the consensus estimate of $86.08 million.

GUIDANCE:

Genomic Health sees FY2017 revenue of $345-355 million, versus the consensus of $356.1 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance